NCT04435912View on ClinicalTrials.gov

Hydrocortisone Per-treatment Decrease Side Effects of Protamine Sulfate

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 4, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

June 1, 2020

Conditions
Blood PressureHeart RateAirway Pressure
Interventions
DRUG

Hydrocortisone 200mg IV

single dose pre-treatment given IV given at the time when the patient is attached to the cardiopulmonary bypass machine

Trial Locations (1)

13133

Faculty of Medicine, Zarqa

All Listed Sponsors
lead

University of Jordan

OTHER

NCT04435912 - Hydrocortisone Per-treatment Decrease Side Effects of Protamine Sulfate | Biotech Hunter | Biotech Hunter